Clin Res Cardiol (2021) DOI DOI https://doi.org/10.1007/s00392-021-01843-w |
||
Predictors of sedation associated complications in patients undergoing left atrial Ablation under Deep sedation with propofol | ||
L. V. Förschner1, N. Harfoush1, M. Thoma1, F. Bourier2, T. Reents2, S. Lengauer1, M. Telishevska1, C. Lennerz3, M.-A. Popa1, S. Maurer1, H. Krafft2, G. Heßling2, I. Deisenhofer2, M. Kottmaier2, für die Studiengruppe: MARS | ||
1Elektrophysiologie, Deutsches Herzzentrum München, München; 2Abteilung für Elektrophysiologie, Deutsches Herzzentrum München, München; 3Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, München; | ||
Background: Catheter ablation for atrial fibrillation (AF) or left
atrial tachycardia (AT) is a well-established treatment option. To avoid body
movement and suppress pain during the procedure sedative agents are commonly
used. Aim of this study was to investigate safety of propofol Methods: Results: Mean procedural duration was 133.7min +/- 52.7min. Mean Propofol dose per kg was 33.7 +/- 16.7mg, mean Midazolam dose was 3mg +/- 11.1mg, mean Fentanyl dose was 0.16mg+/- 2.2mg. One patient (0.03%) needed eIT, n= 47 (1.5%) patients needed NIV. Due to hypotension n=396 patients received noradrenaline, mean oxygen saturation drop was 4.5% +/- 27.5. Patients needing eIT or NIV had significantly longer procedure durations, a higher BMI and CHA2DS2-VASC Score, were significantly older, had a lower GFR, suffered more often from diabetes mellitus and had a lower baseline oxygen saturation. The only predictor for eIT or NIV in the multivariat analysis was a higher BMI (>30.1 +/- 9.0kg/m2). Conclusion: |
||
https://dgk.org/kongress_programme/jt2021/aP1576.html |